|
|
|
|
Carcinogenicity |
|
Oral [Slope Factor]: (see comment) |
1.5E+5 (mg/kg/day)-1 |
|
|
Inhalation [Slope Factor]: (see comment) | 1.5E+5 (mg/kg/day)-1 |
|
|
Oral [Unit Risk]: |
4.5E+0 (µg/L)-1 |
|
Inhalation [Unit Risk]: (see comment) |
3.3E-5 (pg/m3)-1 |
|
|
Route: |
Oral: diet |
|
Target Organ / Cancer: |
Respiratory system / Tumors |
|
Liver / Tumors |
|
Species |
Experiment Length |
EPA Group |
Rat |
720 days |
B2 |
|
References |
1978 | Kociba, R.J., D.G. Keyes, J.E. Bower et al. 1978. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-Tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol. 46(2): 279-303. |
1985 | U.S. EPA. 1985. Health assessment document for Polychlorinated Dibenzo-p-dioxin. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH. EPA 600/8-84-014f. NTIS PB86-122546. |
1984 | U.S. EPA. 1984. Health effects assessment for 2,3,7,8-TCDD. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Emergency and Remedial Response, Washington, DC. |
1989 | U.S. EPA. 1989. Carcinogen Risk Assessment Verification Endeavor (CRAVE) Work Group. |
|
Oral Slope Comment: |
Under review, number subject to change. |
Inhalation Slope Comment: |
See Appendix A-II: Dose Conversions on HEAST. |
Inhalation [Unit Risk] Comment: |
Under review, number subject to change. Based on route to route extrapolation. An absorption factor of 75% is used to calculate the unit risk from the slope factor. |
|